here is one for all the anteo posters that seem to enjoy some of my speculation
in the quarterly " we have recently commenced initial EuGeni overview with a leading German Clinic diagnostic company and we are entering into a CDA to enable further discussions."
I haven't heard of this sort of process being carried out before with other distributors that were signed.
googled leading German clinic diagnostic co. and an old Anteotech friend popped up MERCK.
they supply us with the emporium for our Eugeni platform. Charlie has presented webinars with them about our tests, we were a speaker with Operon at a workshop last year. top executives follow us closely on social media.
then today I found this. a combination of Merck, Anteotech, Axxin reader supplier, Kinematic Aust m/c suppliers
Rapid Point of Care Test Development WorkshopA HANDS-ON MULTI-DAY EXPERIENCE IN PARTNERSHIP WITH KINEMATIC AUTOMATION, ANTEOTECH, AND AXXINMay 3-5, 2022, Seattle, Washington, United Stateshttps://www.sigmaaldrich.com/AU/en/collections/events/e116437762then I remembered this from earlier in the year, about Merck + rapid tests
"The Department of Defense (DOD) announced on Wednesday that it was awarding a $136.7 million contract to the Merck-owned brand MilliporeSigma for the domestic production of a material critical for COVID-19 rapid point-of-care tests."
now any connection between Merck + Anteotech being distribution partners could just be all made up, but come on thats some OK dot joining.
. now I'm sorry to interrupt all this negativity. for me its back to being schooled on why it's a good idea to sell at the low point of where the sp has bounced many times by such knowledgable posters.
have a great day.
2022 the year of ADO, batteries and life science. IMO commercialisation is closer every day.
